[go: up one dir, main page]

UA37238U - Method for primary neuroprotection under conditions of modeling ischemic brain damages - Google Patents

Method for primary neuroprotection under conditions of modeling ischemic brain damages

Info

Publication number
UA37238U
UA37238U UAU200806226U UAU200806226U UA37238U UA 37238 U UA37238 U UA 37238U UA U200806226 U UAU200806226 U UA U200806226U UA U200806226 U UAU200806226 U UA U200806226U UA 37238 U UA37238 U UA 37238U
Authority
UA
Ukraine
Prior art keywords
primary
under conditions
ischemic brain
neuroprotection under
brain damages
Prior art date
Application number
UAU200806226U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрий Михайлович Колесник
Игорь Федорович Беленичев
Светлана Васильевна Горбачева
Андрей Владимирович Абрамов
Владимир Вячеславович Головкин
Нина Викторовна Бухтиярова
Original Assignee
Запорожский Государственный Медицинский Университет
Юрий Михайлович Колесник
Игорь Федорович Беленичев
Светлана Васильевна Горбачева
Андрей Владимирович Абрамов
Владимир Вячеславович Головкин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Запорожский Государственный Медицинский Университет, Юрий Михайлович Колесник, Игорь Федорович Беленичев, Светлана Васильевна Горбачева, Андрей Владимирович Абрамов, Владимир Вячеславович Головкин filed Critical Запорожский Государственный Медицинский Университет
Priority to UAU200806226U priority Critical patent/UA37238U/en
Publication of UA37238U publication Critical patent/UA37238U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Method for primary neuroprotection under conditions of modeling ischemic brain damages includes prescription of neuroprotector to laboratory animal. As neuroprotector one prescribes solution that includes glycerin and magnesium chloride, intraperitoneally, 1 ml per 100 g of weight of animal once per day during 4 days.
UAU200806226U 2008-05-12 2008-05-12 Method for primary neuroprotection under conditions of modeling ischemic brain damages UA37238U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200806226U UA37238U (en) 2008-05-12 2008-05-12 Method for primary neuroprotection under conditions of modeling ischemic brain damages

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200806226U UA37238U (en) 2008-05-12 2008-05-12 Method for primary neuroprotection under conditions of modeling ischemic brain damages

Publications (1)

Publication Number Publication Date
UA37238U true UA37238U (en) 2008-11-25

Family

ID=50553668

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200806226U UA37238U (en) 2008-05-12 2008-05-12 Method for primary neuroprotection under conditions of modeling ischemic brain damages

Country Status (1)

Country Link
UA (1) UA37238U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2818909C1 (en) * 2023-07-13 2024-05-07 Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Method for brain neuroprotection in simulating photoinduced ischemic stroke

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2818909C1 (en) * 2023-07-13 2024-05-07 Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Method for brain neuroprotection in simulating photoinduced ischemic stroke

Similar Documents

Publication Publication Date Title
AU2018260866A1 (en) Selective reduction of allelic variants
GB0920703D0 (en) Compositions containing satiogens and methods of use
MX2012004210A (en) Pyrazole derivatives as modulators of calcium release -activated calcium channel.
MX2009004813A (en) Azaadamantane derivatives and methods of use.
MY171577A (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
MY158257A (en) Forms of rifaximin and uses thereof
EA201201648A1 (en) SGC STIMULATORS
UA107865C2 (en) Heterocyclic carboxamides
ZA201000079B (en) Organic compounds
IN2014KN00948A (en)
IN2012DN03440A (en)
ZA201404444B (en) 4'-azido,3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
IL192333A0 (en) Photobioreactor, system and method for the cultivation of microalgae
MX2010007918A (en) Composition and method for seed treatment use.
PT2940030T (en) Method for producing p1,p4-di(uridine 5'-)tetraphosphate
ZA201306990B (en) Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals
EP2698161A4 (en) COMPOSITION, AGENT ENHANCING GLUCOSE METABOLISM, AND METHOD FOR ENHANCING GLUCOSE METABOLISM
MX2013013891A (en) Anti-scale water treatment system and method.
PL2401263T3 (en) Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
MX2013011996A (en) Methods for regulating sirtuin gene expression.
EP2244561A4 (en) Apparatus for the cultivation of shellfish
MX2010002506A (en) Substituted nicotinamide compounds and the use thereof in pharmaceutical products.
MX2013004878A (en) N-hetarylmethyl pyrazolylcarboxamides.
WO2011122859A3 (en) Composition for predicting chance of brain tumor recurrence and survival prognosis, and kit containing same
EP2675468A4 (en) Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mrna